Format

Send to

Choose Destination
Biotechnol Bioeng. 2019 Oct;116(10):2598-2609. doi: 10.1002/bit.27107. Epub 2019 Jul 21.

Isolating and expanding endothelial progenitor cells from peripheral blood on peptide-functionalized polystyrene surfaces.

Author information

1
Department of Chemical Engineering, McGill University, Montréal, Quebec, Canada.
2
Coronary Care Unit, Montréal Heart Institute, Montréal, Quebec, Canada.
3
Department of Medicine, Université de Montréal, Montréal, Quebec, Canada.
4
Département de Génie des Mines, des Matériaux et de la Métallurgie, Centre de Recherche du CHU de Québec, Université Laval, Quebec City, Quebec, Canada.

Abstract

The expansion of human peripheral blood endothelial progenitor cells to obtain therapeutically relevant endothelial colony-forming cells (ECFCs) has been commonly performed on xeno-derived extracellular matrix proteins. For cellular therapy applications, xeno-free culture conditions are desirable to improve product safety and reduce process variability. We have previously described a novel fluorophore-tagged RGD peptide (RGD-TAMRA) that enhanced the adhesion of mature endothelial cells in vitro. To investigate whether this peptide can replace animal-derived extracellular matrix proteins in the isolation and expansion of ECFCs, peripheral blood mononuclear cells from 22 healthy adult donors were seeded on RGD-TAMRA-modified polystyrene culture surfaces. Endothelial colony formation was significantly enhanced on RGD-TAMRA-modified surfaces compared to the unmodified control. No phenotypic differences were detected between ECFCs obtained on RGD-TAMRA compared to ECFCs obtained on rat-tail collagen-coated surfaces. Compared with collagen-coated surfaces and unmodified surfaces, RGD-TAMRA surfaces promoted ECFC adhesion, cell spreading, and clonal expansion. This study presents a platform that allows for a comprehensive in vitro evaluation of peptide-based biofunctionalization as a promising avenue for ex vivo ECFC expansion.

KEYWORDS:

endothelial progenitor cells; ex vivo expansion; extracellular matrix-derived peptides; surface modification; vascular regeneration; xeno-free

PMID:
31286475
DOI:
10.1002/bit.27107

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center